|
MID2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.85759999896618E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.63340000203638E-08 |
| Normal-vs-Stage2 |
2.328400E-01 |
| Normal-vs-Stage3 |
6.762000E-02 |
| Normal-vs-Stage4 |
3.687800E-02 |
| Stage1-vs-Stage2 |
4.248400E-01 |
| Stage1-vs-Stage3 |
9.698300E-02 |
| Stage1-vs-Stage4 |
8.121200E-01 |
| Stage2-vs-Stage3 |
8.897600E-01 |
| Stage2-vs-Stage4 |
4.990800E-01 |
| Stage3-vs-Stage4 |
2.473200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.78009998039886E-09 |
| Normal-vs-AfricanAmerican |
2.443700E-02 |
| Normal-vs-Asian |
1.914330E-02 |
| Caucasian-vs-AfricanAmerican |
1.153430E-01 |
| Caucasian-vs-Asian |
7.398400E-01 |
| AfricanAmerican-vs-Asian |
7.764800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.95390378823868E-11 |
| Normal-vs-Female |
8.016800E-01 |
| Male-vs-Female |
1.29950000005152E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.783500E-04 |
| Normal-vs-Extreme_Weight |
1.09099995704298E-09 |
| Normal-vs-Obese |
3.557900E-02 |
| Normal-vs-Extreme_Obese |
1.360060E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.583200E-01 |
| Normal_Weight-vs-Obese |
2.169200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.005000E-01 |
| Extreme_Weight-vs-Obese |
9.078400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.278600E-01 |
| Obese-vs-Extreme_Obese |
2.878000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.008400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.647600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.56690005415072E-09 |
| Normal-vs-Age(81-100Yrs) |
1.63643999999685E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.996300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.438100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.466300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.928580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.442000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.8003000180662E-09 |
| Normal-VS-Type2 PRCC |
9.7973000000029E-05 |
| Normal-VS-KIRP CIMP |
9.769200E-01 |
| Normal-VS-Unclassified PRCC |
3.140200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.794800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.361700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.524050E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.331600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.723000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.614200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.27840000386482E-08 |
| Normal-vs-N1 |
9.426300E-02 |
| Normal-vs-N2 |
4.537400E-01 |
| N0-vs-N1 |
5.574100E-02 |
| N0-vs-N2 |
3.773000E-01 |
| N1-vs-N2 |
9.304000E-01 |
|
|
